Home Featured Page 12

Featured

Latest

Pα+ Psychedelic Bulletin #181: Last-Minute Changes to Colorado’s Psychedelics Rules; Cybin’s Impressive 12-Month Data Overshadowed by Small N and Controversial Marketing Move

Sex and Psychedelics: Healing Through Altered States

Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry

Psychedelic Investor Survey Q3 2024

Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

Vital 4: Informational Session and Q+A, with Kyle

Vital 4: Informational Session and Q+A, with David

Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Ayahuasca Traditions Abroad: Forest Medicine in the International Diaspora

Chronic Pain and Inducing Neuroplasticity With Psychedelics

Vital 4: Informational Session and Q+A, with Johanna

Natural Medicine Advisory Bulletin 12: May and June 2024

Symptoms as Signals: Trauma and the Role of Inner Healing Intelligence

Pα+ Psychedelic Bulletin #166: Crenshaw and Musk Weigh In on MDMA;...

Raising the Bar: Why Psychedelic Mentorship is Essential For Professional Development

1...111213...275 Page 12 of 275

Pα+ Psychedelic Bulletin #181: Last-Minute Changes to Colorado’s Psychedelics Rules; Cybin’s...

Sex and Psychedelics: Healing Through Altered States

Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Pα+ Psychedelic Bulletin #181: Last-Minute Changes to Colorado’s Psychedelics Rules; Cybin’s Impressive 12-Month Data Overshadowed by Small N and Controversial Marketing Move

Sex and Psychedelics: Healing Through Altered States

Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry

Psychedelic Investor Survey Q3 2024

Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

Vital 4: Informational Session and Q+A, with Kyle

Vital 4: Informational Session and Q+A, with David

Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Ayahuasca Traditions Abroad: Forest Medicine in the International Diaspora

Chronic Pain and Inducing Neuroplasticity With Psychedelics

Vital 4: Informational Session and Q+A, with Johanna

Natural Medicine Advisory Bulletin 12: May and June 2024

Symptoms as Signals: Trauma and the Role of Inner Healing Intelligence

Pα+ Psychedelic Bulletin #166: Crenshaw and Musk Weigh In on MDMA;...

Raising the Bar: Why Psychedelic Mentorship is Essential For Professional Development

EDITOR PICKS

Pα+ Psychedelic Bulletin #181: Last-Minute Changes to Colorado’s Psychedelics Rules; Cybin’s...

Sex and Psychedelics: Healing Through Altered States

Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY